Cargando…
Current Status of Immune Checkpoint Inhibitors in Gastrointestinal Cancers
The expansion of our understanding of tumor immunity and the recent success of new cancer immunotherapy has reignited the hope that we can treat cancer effectively with immunotherapeutic approaches. Immune checkpoint inhibitors have shown significant efficacy in the treatment of some solid and hemat...
Autores principales: | Kim, Bum Jun, Jang, Hyun Joo, Kim, Hyeong Su, Kim, Jung Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479252/ https://www.ncbi.nlm.nih.gov/pubmed/28638461 http://dx.doi.org/10.7150/jca.18470 |
Ejemplares similares
-
Current Status and Perspective of Immunotherapy in Gastrointestinal Cancers
por: Kim, Jung Hoon, et al.
Publicado: (2016) -
Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017) -
Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review
por: Kim, Bum Jun, et al.
Publicado: (2017) -
Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017) -
Current status of treatment with immune checkpoint inhibitors for
gastrointestinal, hepatobiliary, and pancreatic cancers
por: Eso, Yuji, et al.
Publicado: (2020)